AVITHRAPID
@avithrapid.bsky.social
The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.
AVITHRAPID enters 2026 with renewed momentum.
This year we’ll accelerate small-molecule discovery, expand AI-driven screening, strengthen EU collaborations, and advance tools for faster pandemic preparedness.
👉 Stay connect:
This year we’ll accelerate small-molecule discovery, expand AI-driven screening, strengthen EU collaborations, and advance tools for faster pandemic preparedness.
👉 Stay connect:
Newsletter - AVITHRAPID project
Sign up Sign up and stay informed about the progress and developments of the AVITHRAPID project. You can unsubscribe at any time by clicking the link in the footer of the newsletter E-mails. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices. Newsletter Archive Newsletter 3 November 2025 Newsletter 16 June 2025 Newsletter 10 March 2025 Newsletter 4 November 2024
avithrapid.eu
January 2, 2026 at 3:00 PM
AVITHRAPID enters 2026 with renewed momentum.
This year we’ll accelerate small-molecule discovery, expand AI-driven screening, strengthen EU collaborations, and advance tools for faster pandemic preparedness.
👉 Stay connect:
This year we’ll accelerate small-molecule discovery, expand AI-driven screening, strengthen EU collaborations, and advance tools for faster pandemic preparedness.
👉 Stay connect:
avithrapid.eu/survey/
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
Survey - AVITHRAPID project
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.
avithrapid.eu
December 29, 2025 at 6:00 PM
avithrapid.eu/survey/
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
avithrapid.eu/survey/
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
Survey - AVITHRAPID project
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.
avithrapid.eu
December 23, 2025 at 2:24 PM
avithrapid.eu/survey/
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
#AVITHRAPID launches its international #PublicOpinionSurvey to understand how #pandemicspreparedness, and antiviral research are perceived by society.
Your voice matters in building a more prepared and resilient future.
2025 was a key year for #AVITHRAPID 🚀
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.
Thank you to all partners - onward to 2026!
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.
Thank you to all partners - onward to 2026!
December 23, 2025 at 2:17 PM
2025 was a key year for #AVITHRAPID 🚀
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.
Thank you to all partners - onward to 2026!
From strengthening European collaborations to advancing antiviral research and knowledge sharing, we worked together to improve #pandemicpreparedness and #globalhealth resilience.
Thank you to all partners - onward to 2026!
Universal Health Coverage Day.
Preparedness is part of universal health.
AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.
#AVITHRAPID #GlobalHealth
Preparedness is part of universal health.
AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.
#AVITHRAPID #GlobalHealth
December 12, 2025 at 11:57 AM
Universal Health Coverage Day.
Preparedness is part of universal health.
AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.
#AVITHRAPID #GlobalHealth
Preparedness is part of universal health.
AVITHRAPID contributes by advancing antiviral research and strengthening future response capacities.
#AVITHRAPID #GlobalHealth
Epidemic = local surge.
Pandemic = global spread.
Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.
#AVITHRAPID #Preparedness
Pandemic = global spread.
Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.
#AVITHRAPID #Preparedness
December 9, 2025 at 1:45 PM
Epidemic = local surge.
Pandemic = global spread.
Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.
#AVITHRAPID #Preparedness
Pandemic = global spread.
Severity isn’t what defines a pandemic - reach does.
COVID-19 proved how fast that jump can happen.
#AVITHRAPID #Preparedness
At SC25 (Nov 2025, St. Louis), @it4innovations.bsky.social showcased AVITHRAPID - highlighting how high-performance computing fuels the next generation of antiviral research.
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research
December 3, 2025 at 8:27 AM
At SC25 (Nov 2025, St. Louis), @it4innovations.bsky.social showcased AVITHRAPID - highlighting how high-performance computing fuels the next generation of antiviral research.
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research
Thank you, IT4Innovations!
#AVITHRAPID #SC25 #HPC #Research
Targeting the virus is not enough.
AVITHRAPID explores host-directed antivirals, reducing resistance and enabling broad-spectrum preparedness.
Innovation for future pandemics.
🔗 avithrapid.eu/newsle...
#AVITHRAPID #AntiviralResearch
AVITHRAPID explores host-directed antivirals, reducing resistance and enabling broad-spectrum preparedness.
Innovation for future pandemics.
🔗 avithrapid.eu/newsle...
#AVITHRAPID #AntiviralResearch
Newsletter - AVITHRAPID project
Sign up Sign up and stay informed about the progress and developments of the AVITHRAPID project. You can unsubscribe at any time by clicking the link in the footer of the newsletter E-mails. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices. Newsletter Archive Newsletter 3 November 2025 Newsletter 16 June 2025 Newsletter 10 March 2025 Newsletter 4 November 2024
avithrapid.eu
November 25, 2025 at 7:04 AM
Targeting the virus is not enough.
AVITHRAPID explores host-directed antivirals, reducing resistance and enabling broad-spectrum preparedness.
Innovation for future pandemics.
🔗 avithrapid.eu/newsle...
#AVITHRAPID #AntiviralResearch
AVITHRAPID explores host-directed antivirals, reducing resistance and enabling broad-spectrum preparedness.
Innovation for future pandemics.
🔗 avithrapid.eu/newsle...
#AVITHRAPID #AntiviralResearch
🌐 AVITHRAPID Project Portal - your gateway to antiviral R&D and pandemic preparedness.
🔗 Discover more: avithrapid.eu/projec...
#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"
🔗 Discover more: avithrapid.eu/projec...
#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"
November 20, 2025 at 7:03 AM
🌐 AVITHRAPID Project Portal - your gateway to antiviral R&D and pandemic preparedness.
🔗 Discover more: avithrapid.eu/projec...
#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"
🔗 Discover more: avithrapid.eu/projec...
#AVITHRAPID #InnovationGateway #AntiviralResearch #Preparedness"
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
November 12, 2025 at 8:35 AM
AVITHRAPID evolves! 🧬
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
A new Training section is now live on our website - open to everyone interested in infectious diseases, small molecules, and AI-driven antiviral discovery.
🔗 Explore it here: avithrapid.eu/training/
#AVITHRAPID #ScienceEducation #AI #DrugDiscovery
Small molecules are a flexible and scalable tool for new and resistant viruses.
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
November 4, 2025 at 12:11 PM
Small molecules are a flexible and scalable tool for new and resistant viruses.
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
AVITHRAPID puts them at the core of our antiviral strategy.
#Antivirals #Innovation #AVITHRAPID
avithrapid.eu/europe...
At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach
At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach
European Researchers' Night at Frascati Scienza - AVITHRAPID project
Frascati Scienza celebrated 20 years of science, passion, and curiosity with the 2025 edition of the European Researchers’ Night. The event filled squares, schools, museums, and institutions throughout Italy with a week packed with events dedicated to scientific dissemination: a journey through STEAM – Science, Technology, Engineering, Art, and Mathematics – culminating on September 26, 2025, with the European Researchers’ Night. The European Researchers’ Night was the opportunity to introduce the AVITHRAPID project to the research community and the general public. It brought its results to researchers closer to the public, attracting over 30.000 visitors to all events, while increasing the interest of young people in science and research careers and showing how researchers’ work affects our daily lives. Francesca Ceccherini Silberstein with her team from University of Rome Tor Vergata distributed and illustrated some dissemination material prepared for this specific event. Poster
avithrapid.eu
October 24, 2025 at 6:15 PM
avithrapid.eu/europe...
At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach
At the end of September, Frascati Scienza celebrated 20 years of science during the European Researchers’ Night 2025 🇪🇺
Through Tor Vergata University, AVITHRAPID engaged with the public, sharing advances in antiviral research.
#AVITHRAPID #ERN2025 #ScienceOutreach
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
October 23, 2025 at 2:24 PM
20th October AVITHRAPID hosted a seminar with the APPEAL project, fostering an inspiring exchange of ideas within the #HorizonEU framework.
Today is Global Handwashing Day.
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
October 15, 2025 at 12:18 PM
Today is Global Handwashing Day.
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Hand hygiene prevents infections, yet the development of antivirals and small molecules is essential to tackle emerging viruses and safeguard public health.
#GlobalHandwashingDay #HealthInnovation #DrugDiscovery #Science
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
October 9, 2025 at 7:02 AM
Small molecules are key to the future of antivirals: fast to develop, easy to deliver, globally accessible.
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
At AVITHRAPID, we put them at the core of our mission to protect against emerging viruses.
#AVITHRAPID #Antivirals #DrugDiscovery
💊 Small molecules = game-changer for antivirals.
Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure
Vote & share your view in the comments!
#AVITHRAPID #Antivirals #DrugDiscovery #Biotech
Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure
Vote & share your view in the comments!
#AVITHRAPID #Antivirals #DrugDiscovery #Biotech
September 30, 2025 at 7:19 AM
💊 Small molecules = game-changer for antivirals.
Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure
Vote & share your view in the comments!
#AVITHRAPID #Antivirals #DrugDiscovery #Biotech
Where is their biggest impact?
- Emerging viral threats
- Resistant strains
- Global access
- Other / not sure
Vote & share your view in the comments!
#AVITHRAPID #Antivirals #DrugDiscovery #Biotech
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
September 23, 2025 at 3:29 PM
AVITHRAPID will be at the European Researchers’ Night on 26 Sept in Italy 🇮🇹.
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
Our scientists will share how small molecules and advanced research shape the future of antivirals.
#AVITHRAPID #ERN2025 #Innovation
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
September 18, 2025 at 7:38 AM
AVITHRAPID will be part of Settimana della Scienza in Italy (20–27 Sept) 🇮🇹 through our partner Tor Vergata University.
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
At their stand, you can learn more about our mission and the future of antiviral drug discovery.
Program: www.frascatiscienza....
#AVITHRAPID #ScienceWeek #ERN2025
AI is changing healthcare 🚀
But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear
Cast your vote ⬇️
#AVITHRAPID #Innovation #DrugDiscovery
But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear
Cast your vote ⬇️
#AVITHRAPID #Innovation #DrugDiscovery
September 15, 2025 at 12:19 PM
AI is changing healthcare 🚀
But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear
Cast your vote ⬇️
#AVITHRAPID #Innovation #DrugDiscovery
But when it comes to drug discovery, which impact do you see first?
- Speed of development
- Personalized therapies
- Cost savings
- Still unclear
Cast your vote ⬇️
#AVITHRAPID #Innovation #DrugDiscovery
Our recent poll sparked a key conversation:
🧬 Vaccines prevent
💊 Antivirals treat
Both are essential pillars of #globalhealth.
At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.
🧬 Vaccines prevent
💊 Antivirals treat
Both are essential pillars of #globalhealth.
At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.
September 11, 2025 at 1:08 PM
Our recent poll sparked a key conversation:
🧬 Vaccines prevent
💊 Antivirals treat
Both are essential pillars of #globalhealth.
At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.
🧬 Vaccines prevent
💊 Antivirals treat
Both are essential pillars of #globalhealth.
At #AVITHRAPID, we’re working to accelerate antiviral research - ensuring faster, safer, and smarter therapies that complement vaccines.
🧪 Vaccines prevent. Antivirals treat.
Both are vital — but which will shape the future of infectious disease? 🦠
Vaccines
Antivirals
Both equally
Not sure
👉 Vote in the poll and share your thoughts in the comments!
Your perspective matters for the future of global health.
Both are vital — but which will shape the future of infectious disease? 🦠
Vaccines
Antivirals
Both equally
Not sure
👉 Vote in the poll and share your thoughts in the comments!
Your perspective matters for the future of global health.
September 8, 2025 at 6:05 PM
🧪 Vaccines prevent. Antivirals treat.
Both are vital — but which will shape the future of infectious disease? 🦠
Vaccines
Antivirals
Both equally
Not sure
👉 Vote in the poll and share your thoughts in the comments!
Your perspective matters for the future of global health.
Both are vital — but which will shape the future of infectious disease? 🦠
Vaccines
Antivirals
Both equally
Not sure
👉 Vote in the poll and share your thoughts in the comments!
Your perspective matters for the future of global health.
AVITHRAPID and Area Science Park just published an annoucement about their new partnership to drive antiviral and preventive innovation.
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation
AVITHRAPID and Area Science Park Join Forces to Drive Antiviral Innovation - AVITHRAPID project
AVITHRAPID has signed a new Memorandum of Understanding (MoU) with Area Science Park, a leading Italian research hub, to accelerate innovation in antiviral therapeutics and preventive strategies. This agreement marks a significant step forward in strengthening Europe’s ability to anticipate, prevent, and respond to future infectious disease threats. At its core lies a shared ambition: […]
avithrapid.eu
September 3, 2025 at 6:43 PM
AVITHRAPID and Area Science Park just published an annoucement about their new partnership to drive antiviral and preventive innovation.
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation
The MoU strengthens Europe’s scientific response to future health threats.
📰 Read more: avithrapid.eu/avithr...
#AVITHRAPID #ScienceFeed #PublicHealth #Innovation
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
August 27, 2025 at 4:39 PM
AVITHRAPID is advancing broad-spectrum antivirals across Europe — and we’re sharing it with you.
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Subscribe to our newsletter for updates on research, events, partnerships & more.
📩 avithrapid.eu/newsle...
#AVITHRAPID #ScienceFeed #PublicHealth
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
August 19, 2025 at 3:32 PM
Broad-spectrum antivirals (BSAs) target host or conserved viral parts, working across virus families. They deploy fast and aid pandemic prep without needing virus ID. Trade-offs: toxicity, resistance risk, less precision. Still, BSAs could be key for unpredictable outbreaks. #HealthTech #Science
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
August 13, 2025 at 11:43 AM
It’s #WorldBreastfeedingWeek - a reminder that science must reflect everyone’s needs.
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity
At #AVITHRAPID, we believe preparedness means inclusion, equity and long-term impact.
#ScienceFeed #HealthEquity